|
|
The 3rd World Congress on
Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy)
Hilton Hotel, Prague, Czech Republic, May 13-16, 2010 |
|
| |
| Friday, May 14, 2010 |
 |
|
|
HALL A |
|
08:15-10:00
08:15-08:30 |
Plenary Session 1
OUTCOME STUDIES IN THE TREATMENT OF TYPE 2 DIABETES (T2D)
Chairpersons: S. Del Prato, Italy I. Raz, Israel |
|
08:30-09:00
09:00-09:20
09:20-09:40
09:40-10:00 |
Diabetes and Cancer
S. Del Prato, Italy
Implications of the new regulatory guidelines: Cardiovascular outcome studies as an integral part of the development process of novel anti diabetic drugs B. Hirshberg, Israel
What can be learnt from the new ACCORD sub-analysis?
H. Ginsberg, USA
Act now
R.A. DeFronzo, USA
|
|
10:30-12:30
10:30-10:35 |
GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISTS AND DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS: A CLINICAL COMPARISON
Chairperson: J.J. Holst, Denmark |
|
10:35-11:05
10:35-10:50
10:50-11:05
11:05-11:20
11:20-12:00
11:20:11:40
11:40-12:00
12:00-12:30 |
Impact of glycaemic control impact on body weight potential to reduce cardiovascular (CV) risk
GLP-1: G. Sesti, Italy
DPP-4: D. Dicker, Israel
AUDIENCE DISCUSSION
Beta-cell protection
Animal studies: M. Donath, Switzerland
Human perspective: A.J. Garber, USA
PANEL DISCUSSION
D. Dicker, Israel M. Donath, Switzerland A.J. Garber, USA G. Sesti, Italy
|
| 13:30-14:15 |
GUIDED POSTER TOUR#1
Poster Presentation Area |
|
|
| 13:30-14:15 |
Session 5
NORMALIZING A1C – EFFICACY AND SAFETY OF NEW NOVEL DRUGS
R.A. DeFronzo, USA |
|
|
|
14:15-16:00
14:15-14:20 |
THERAPY IN THE EARLY STAGE
Chairperson: A. Ametov, Russia J. Meigs, USA |
|
14:20-14:50
14:20-14:35
14:35-14:50
14:50-15:05
15:05-15:35
15:05-15:20
15:20-15:35
15:35-16:00
|
Pharmacologic prevention of T2DM
Pro: R.A. DeFronzo, USA
Con: J. Tuomilehto, Finland
AUDIENCE DISCUSSION
Metformin failure: What is next?
Incretins: S. Del Prato, Italy
Others: I. Raz, Israel
PANEL DISCUSSION
R.A. DeFronzo, USA S. Del Prato, Italy I. Raz, Israel J. Tuomilehto, Finland
|
|
16:30-18:30
|
Session 9
T2D IN CHILDHOOD
Chairpersons: R. Bonadonna, Italy S. Cernea, Romania |
|
16:35-16:55
16:55-17:15
17:15-17:35
17:35-17:55
17:55-18:30
|
Epidemiology and pathophysiology
S. Caprio, USA
Metabolic syndrome in pediatrics
R. Weiss, Israel
The accelerator hypothesis and the double diabetes
P. Pozzilli, Italy
Treatment of T2D in youth: What's on the horizon?
S. Arslanian, USA
PANEL DISCUSSION
S. Arslanian, USA S. Caprio, USA P. Pozzilli, Italy R. Weiss, Israel
|
|
HALL B |
|
10:30-12:30
10:30-10:35 |
OPTIMAL BLOOD PRESSURE CONTROL
Chairperson: G. Mancia, Italy Y. Yodfat, Israel |
|
10:35-11:05
10:35-10:50
10:50-11:05
11:05-11:20
11:20-12:00
11:20-11:40
11:40-12:00
12:00-12:30 |
The blood pressure legacy
Pro: L.M. Ruilope, Spain
Con: G. Parati, Italy
AUDIENCE DISCUSSION
Blood pressure: The lower, the better
Pro: G. Mancia, Italy
Con: E. Grossman, Israel
PANEL DISCUSSION
G. Mancia, Italy G. Parati, Italy L. Ruilope, Spain E. Grossman, Israel
|
| 13:30-14:15 |
GUIDED POSTER TOUR#1
Poster Presentation Area |
|
|
|
14:15-16:00
14:15-14:20 |
Session 7
HYPERTENSION TREATMENT
Chairperson: E. Grossman, Israel |
|
14:20-14:45
14:45-15:15
14:45-15:00
15:00-15:15
15:15-16:00 |
Are the benefits of RAS blockage beyond BP lowering in CV prevention?
Y. Yodfat, Israel
Diuretic treatment of hypertension
Pro: E. Grossman, Israel
Con: P. Verdecchia, Italy
PANEL DISCUSSION
E. Grossman, Israel P. Verdecchia, Italy Y. Yodfat, Israel
|
|
16:30-18:30
|
Session 10
RENIN-ANGIOTENSIN SYSTEM (RAS) AND COMPLICATIONS
Chairperson: L.M. Ruilope, Spain |
|
16:35-17:05
16:35-16:50
16:50-17:05
17:05-17:20
17:20-17:50
17:20-17:35
17:35-17:50
17:50-18:30 |
Estimated glomerular filtration rate (eGFR) or albuminuria as predictors for renal and CV outcome
eGFR: M. Ravid, Israel
Albuminuria: D. de Zeeuw, Netherlands
AUDIENCE DISCUSSION
RAS blockade for every diabetic
Pro: L.M. Ruilope, Spain
Con: A. Solini, Italy
PANEL DISCUSSION
D. de Zeeuw, Netherlands M. Ravid, Israel L.M. Ruilope, Spain A. Solini, Italy
|
|
HALL C |
|
10:30-12:30
10:30-10:35 |
Session 4
OBESITY: CAUSE AND DIFFERENT APPROACHES
Chairperson: E. Ravussin, USA |
|
10:35-10:55
10:55-11:15
11:15-11:35
11:35-11:55
11:55-12:30 |
Should obesity be treated at any age?
R. Bonadonna, Italy
Physical exercise. How and how much?
P. De Feo, Italy
Effective diet for weight loss
I. Shai, Israel
Caloric restriction Vs bariatric surgery
E. Ravussin, USA
PANEL DISCUSSION
R. Bonadonna, Italy P. De Feo, Italy E. Ravussin, USA I. Shai, Israel
|
| 13:30-14:15 |
GUIDED POSTER TOUR#1
Poster Presentation Area |
|
|
|
14:15-16:00
14:15-14:20 |
GLUCOSE VARIABILITY
Chairpersons: R. Niecestro, USA M. Petkova, Bulgaria |
|
14:20-14:50
14:20-14:35
14:35-14:50
14:50-15:05
15:05-15:35
15:05-15:20
15:20-15:35
15:35-16:00 |
Postprandial glucose and glucose variability. Should we care?
Pro: A. Ceriello, UK
Con: E. Standl, Germany
AUDIENCE DISCUSSION
Continuous glucose monitoring (closing the loop)
Expectations: M. Phillip, Israel
Doubts: J.H. DeVries, Netherlands
PANEL DISCUSSION
A. Ceriello, UK J.H. DeVries, Netherlands M. Philip, Israel E. Standl, Germany
|
|
16:30-18:30
16:30-16:35 |
Session 11
BLOOD VESSELS, ENDOTHELIUM AND METABOLIC DISEASES
Chairperson: C.D.A. Stehouwer, Netherlands |
|
16:35-16:55
16:55-17:15
17:15-17:35
17:35-17:55
17:55-18:30 |
Inflammation and innate immunity
J.M. Fernández-Real, Spain
The role of metalloproteinases. At the interface between metabolic and inflammatory disorders
M. Federici, Italy
Vascular disease in diabetes. The role of reparatory mechanisms
A. Avogaro, Italy
Endothelial factors and diabetic nephropathy
L. Gnudi, UK
PANEL DISCUSSION
A. Avogaro, Italy M. Federici, Italy J.M. Fernández-Real, Spain L. Gnudi, UK |
|
|
|
|
WebStudio.co.il